Search results
Why Your Migraines Get Worse When It's Hot Outside
SciTechDaily· 17 hours agoA recent study involving multiple research institutions found that increases in temperature significantly raise the likelihood of migraine attacks. The...
Concerpt Therapeutics Shares Are Trading Lower: What You Need To Know - Corcept Therapeutics...
Benzinga· 22 hours agoCorcept Therapeutics Inc. (NASDAQ: CORT) shares are trading lower Friday afternoon following a report suggesting Teva Pharmaceuticals Inc. (NYSE: TEVA) has sued the company, accusing it of a monopoly on Korlym.
If You Invested $1000 In This Stock 5 Years Ago, You Would Have $2,100 Today - Teva Pharmaceutical...
Benzinga· 3 days agoTeva Pharmaceutical Indus TEVA has outperformed the market over the past 5 years by 2.48% on an annualized basis producing an average annual return of 15.66% ...
Amneal, US FTC win order removing Teva inhaler patents from FDA list
Reuters· 5 days agoDrugmaker Amneal Pharmaceuticals with the backing of the U.S. Federal Trade Commission convinced a New Jersey federal court on Monday to remove five Teva Pharmaceutical patents ...
JD Supra: Federal Circuit Review
JD Supra· 6 days agoIn Janssen Pharmaceuticals, Inc. v. Teva Pharmaceuticals Usa, Inc., Appeal No. 22-1258, the Federal Circuit held that district court erred by adding unclaimed limitations ...
ADHD Drug Shortage Could Worsen After Arrests Of 2 Telehealth Executives, CDC Warns
Forbes· 1 day agoThe arrests of two executives of a large telehealth medication company may worsen an almost two-year...
AbbVie joins in latest gastrointestinal drug chase
BioPharma Dive via Yahoo Finance· 1 day agoThe Illinois-based drugmaker is following rivals like Merck, Roche, Teva and Sanofi, which have piled billions of dollars into acquisitions to gain...
Screaming hairy armadillo pups welcomed at New Orleans zoo
FOX 13 Tampa Bay· 6 days agoThe Audubon Zoo celebrated the birth of a special set of twins: two screaming hairy armadillo pups....
AbbVie (ABBV) Buys Global Rights to Novel IBD Candidate
Zacks· 1 day agoAbbVie (ABBV) signs an exclusive global licensing deal with the Chinese company FutureGen to develop FG-M701, a next-generation TL1A antibody, for IBD indications.
Scientists find a link between increased headaches and hotter temperatures for individuals with...
Medical Xpress· 17 hours ago"Weather change is one of the most common trigger factors for migraine," says Vincent Martin, MD,...